Health related quality of life outcomes for unresectable stage III or IV melanoma patients receiving ipilimumab treatment

D.A. Revicki; A.J.M. van den Eertwegh; P. Lorigan; C. Lebbe; G. Linette; C.H. Ottensmeier; S. Safikhani; M. Messina; A. Hoos; S. Wagner; S. Kotapati

doi:10.1186/1477-7525-10-66

Health related quality of life outcomes for unresectable stage III or IV melanoma patients receiving ipilimumab treatment

D.A. Revicki
, A.J.M. van den Eertwegh
, P. Lorigan
, C. Lebbe
, G. Linette
, C.H. Ottensmeier
, S. Safikhani
, M. Messina
, A. Hoos
, S. Wagner
, S. Kotapati

Affiliatie VU

Research output: Contribution to journal › Article › Academic › peer-review

29 Downloads (Pure)

Original language	Undefined/Unknown
Article number	66
Journal	Health and quality of life outcomes
Volume	10
DOIs	https://doi.org/10.1186/1477-7525-10-66
Publication status	Published - 2012

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1186/1477-7525-10-66

302196Final published version, 461 KB

Cite this

Revicki, D. A., van den Eertwegh, A. J. M., Lorigan, P., Lebbe, C., Linette, G., Ottensmeier, C. H., Safikhani, S., Messina, M., Hoos, A., Wagner, S., & Kotapati, S. (2012). Health related quality of life outcomes for unresectable stage III or IV melanoma patients receiving ipilimumab treatment. Health and quality of life outcomes, 10, Article 66. https://doi.org/10.1186/1477-7525-10-66

@article{39847ed7b51944ba80fd5b79fd7af5f1,

title = "Health related quality of life outcomes for unresectable stage III or IV melanoma patients receiving ipilimumab treatment",

author = "D.A. Revicki and \{van den Eertwegh\}, A.J.M. and P. Lorigan and C. Lebbe and G. Linette and C.H. Ottensmeier and S. Safikhani and M. Messina and A. Hoos and S. Wagner and S. Kotapati",

year = "2012",

doi = "10.1186/1477-7525-10-66",

language = "Undefined/Unknown",

volume = "10",

journal = "Health and quality of life outcomes",

issn = "1477-7525",

publisher = "BioMed Central Ltd.",

}

TY - JOUR

T1 - Health related quality of life outcomes for unresectable stage III or IV melanoma patients receiving ipilimumab treatment

AU - Revicki, D.A.

AU - van den Eertwegh, A.J.M.

AU - Lorigan, P.

AU - Lebbe, C.

AU - Linette, G.

AU - Ottensmeier, C.H.

AU - Safikhani, S.

AU - Messina, M.

AU - Hoos, A.

AU - Wagner, S.

AU - Kotapati, S.

PY - 2012

Y1 - 2012

U2 - 10.1186/1477-7525-10-66

DO - 10.1186/1477-7525-10-66

M3 - Article

C2 - 22694829

SN - 1477-7525

VL - 10

JO - Health and quality of life outcomes

JF - Health and quality of life outcomes

M1 - 66

ER -